About Us

Shenyang Dasan Pharmaceutical Technology Co., Ltd. (est. 2014, registered capital 15.45M RMB) locates in Shenyang International Software Park. As a national high-tech enterprise, it focuses on process development and industrialization of complex oral formulations, conventional liquid formulations, functional health foods, and medical devices. Three tech platforms: taste masking, poorly soluble drug microencapsulation, and sustained/controlled-release pellets. Key areas: pediatric, geriatric, and novel controlled-release drugs.
The company provides full lifecycle services (R&D → production → registration → marketing) as a “pharmaceutical R&D + MAH B-certificate holder”. It has a complete MAH system with B license, and departments covering R&D, project management, manufacturing, QA, pharmacovigilance, registration, logistics support, and operation support. The R&D team consists of doctors, masters, and bachelors in pharmaceutical analysis, pharmaceutics, pharmacology, etc., with strong experience.
Date of Establishment July 2014
Company Type Sino-foreign Joint Venture
Legal Representative YOO HYOUNG SUN
Registered Capital RMB 15.45 Million
Business Scope Pharmaceutical R&D, Pharmaceutical Sales, Pharmaceutical Import & Export, Cosmetics & Health Product Sales, etc.
Company Address Room F9-310, No. 860-6, Shangshangou Village, Hunnan District, Shenyang City, Liaoning Province

Company Vision

Leveraging a professional team to build an R&D + MAH platform and achieve the commercial success of the "DASAN" brand in China.

R&D Platform
+
MAH Platform
=
Commercial Success

Company Mission

Achieve the organic integration of Technical Services, R&D, and MAH to drive rapid growth of DASAN in the Chinese market.

Technical Services

Tech Service

R&D Innovation

R&D Innovation

MAH Platform

MAH Platform

Organic Integration to Drive Rapid Growth

Core Strategy Overview

Five Pillars Working in Synergy to Advance the Commercialization of the DASAN Brand in China

R&D

Build MINI-CR and MINI-DosEZ novel drug technology platforms based on generic drugs.

MAH

Establish a compliant and efficient MAH platform to accelerate the development of self-held products.

HDP

Actively participate in HDP development and promote HDP as the core manufacturing base for DASAN MAH products.

MARKET

Accelerate market entry of MAH products to achieve diversified revenue streams.

COMPLIANCE

Upgrade GMP standards and strengthen MAH and financial compliance.

Company Video